• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER PICCOLO; OCCLUDER, PATENT DUCTUS, ARTERIOSUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER PICCOLO; OCCLUDER, PATENT DUCTUS, ARTERIOSUS Back to Search Results
Model Number OCCLUDER
Device Problems Migration or Expulsion of Device (1395); Improper or Incorrect Procedure or Method (2017)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/15/2022
Event Type  Injury  
Event Description
It was reported that on (b)(6) 2022, a 4mm by 4mm amplatzer piccolo occluder was chosen for implant in a 5-week old, 1.8 kg patient.During procedure, the device was implanted.A few minutes after the device was released from the delivery cable, the device embolized.The device was then successfully retrieved and removed from the patient.The patient status was reported as stable.
 
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Subsequent to the previously filed report, additional information was received that an abbott delivery system was used to implant the 4mm by 4mm amplatzer piccolo occluder (lot 6816151).The patent ductus arteriosus (pda) dimensions were minimal diameter 3.2 mm, length of 8 mm, and diameter at aortic ampulla of 4.4 mm.The device was placed intraductal.After the device completely dislodged from the implant site, the device travelled to the patient's left pulmonary artery.The device was retrieved via transcatheter snare.The device was replaced with a 5mm by 2mm amplatzer piccolo occluder (lot unknown).The patient remained hemodynamically stable throughout the procedure.There was no clinically significant delay in procedure and no adverse patient effects.The physician was aware that the recommended sizing per instructions for use (ifu) of the amplatzer piccolo occluder was 4mm by 2mm, but the other sized devices were chosen due to patient anatomical variation and physician preference.The other sized devices, the 4mm by 4mm amplatzer piccolo occluder and then the 5mm by 2mm amplatzer piccolo occluder, were chosen instead because it was believed that the longer length of the device would have more tissue contact with the pda.
 
Manufacturer Narrative
An event of embolism of a 4/4mm piccolo device was reported.A returned device assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications and no similar complaints were found in a review of complaints on the batch.Based on the information received, the cause of the reported incident could not be conclusively determined; however the miss-sizing of the device could have contributed to the reported embolization.There is no indication of a product quality issue with regards to manufacture design or labeling.Please note, per the sizing table in the instructions for use, the recommended size device for a pda of a minimal diameter of 3.2mm, aortic ampulla diameter of 4.4mm and pda length of 8mm was a 4/2mm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PICCOLO
Type of Device
OCCLUDER, PATENT DUCTUS, ARTERIOSUS
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key15393612
MDR Text Key299597946
Report Number2135147-2022-01075
Device Sequence Number1
Product Code MAE
UDI-Device Identifier05415067031013
UDI-Public05415067031013
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/09/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2023
Device Model NumberOCCLUDER
Device Catalogue Number9-PDAP-04-04-L
Device Lot Number6816151
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/13/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/17/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age5 WK
Patient SexMale
Patient Weight2 KG
-
-